Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Apollo Endosurgery Inc    LPTN

APOLLO ENDOSURGERY INC

(LPTN)
My previous session
Most popular
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
03/18/2019 03/19/2019 03/20/2019 03/21/2019 03/22/2019 Date
3.25(c) 3.37(c) 3.62(c) 3.82(c) 4(c) Last
24 420 12 710 14 787 13 406 5 545 Volume
-2.11% +3.69% +7.42% +5.52% +4.71% Change
More quotes
Financials (USD)
Sales 2019 55,6 M
EBIT 2019 -32,5 M
Net income 2019 -36,3 M
Debt 2019 -
Yield 2019 -
Sales 2020 61,4 M
EBIT 2020 -22,9 M
Net income 2020 -32,0 M
Debt 2020 -
Yield 2020 -
P/E ratio 2019 -
P/E ratio 2020
Capi. / Sales2019 1,58x
Capi. / Sales2020 1,43x
Capitalization 87,7 M
More Financials
Company
Apollo Endosurgery, Inc., formerly Lpath, Inc., is a medical device company. The Company is focused on less invasive therapies for the treatment of obesity, as well as other gastrointestinal disorders. The Company's device-based therapies are an alternative to invasive surgical procedures. The... 
More about the company
Surperformance© ratings of Apollo Endosurgery Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on APOLLO ENDOSURGERY INC
03/18APOLLO ENDOSURGERY, INC. : Results of Operations and Financial Condition, Financ..
AQ
03/18APOLLO ENDOSURGERY : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION..
AQ
03/05APOLLO ENDOSURGERY, INC. : Change in Directors or Principal Officers, Financial ..
AQ
2018APOLLO ENDOSURGERY, INC. : Entry into a Material Definitive Agreement, Completio..
AQ
2018APOLLO ENDOSURGERY : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION..
AQ
2018APOLLO ENDOSURGERY, INC. : Results of Operations and Financial Condition, Financ..
AQ
2018APOLLO ENDOSURGERY : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION..
AQ
2018APOLLO ENDOSURGERY, INC. : Results of Operations and Financial Condition, Financ..
AQ
2018APOLLO ENDOSURGERY : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION..
AQ
2018APOLLO ENDOSURGERY, INC. : Reports Second Quarter 2018 Results
BU
More news
Sector news : Medical Equipment
03:55aMedical device maker ConvaTec names Genus top boss as CEO
RE
03/22HUBERT SAGNIÈRES : Executive Spat Trips Up Ray-Ban Owner -- WSJ
DJ
03/21BECTON DICKINSON AND : Responds to FDA Letter on Paclitaxel-Coated Devices
DJ
03/21ESSILORLUXOTTICA : Executive Quarrel Trips Up Eyewear Giant Months After Merger
DJ
03/21European stocks slip as banks slide, London shares jump
RE
More sector news : Medical Equipment
Chart APOLLO ENDOSURGERY INC
Duration : Period :
Apollo Endosurgery Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends APOLLO ENDOSURGERY INC
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 3
Average target price 6,50 $
Spread / Average Target 63%
EPS Revisions
Managers
NameTitle
Todd Newton Chief Executive Officer & Director
Richard J. Meelia Chairman
Stefanie Cavanaugh Chief Financial Officer & Secretary
Christopher J. Gostout Chief Medical Officer
Matthew S. Crawford Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
APOLLO ENDOSURGERY INC15.94%88
ABBOTT LABORATORIES7.80%136 952
MASIMO CORPORATION24.50%7 108
ASAHI INTECC CO., LTD.14.63%6 115
PENUMBRA INC29.26%5 474
JIANGSU YUYUE MDCL EQPMNT & SPPLY CO LTD--.--%3 602